Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Risk | Very High | - |
Rating | 2.0 | - |
Min SIP Amount | ₹500 | - |
Expense Ratio | 1.77 | - |
NAV | ₹35.95 | - |
Fund Started | 20 Apr 2017 | - |
Fund Size | ₹5719.59 Cr | - |
Exit Load | Exit load of 1% if redeemed within 3 months. | - |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 3.56% | - |
3 Year | 20.04% | - |
5 Year | 24.94% | - |
1 Year
3 Year
5 Year
Equity | 96.15% | - |
Cash | 3.85% | - |
Equity
Cash
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
Glenmark Pharmaceuticals Ltd. | 3.38% |
ICICI Bank Ltd. | 3.31% |
Divi's Laboratories Ltd. | 3.03% |
Laurus Labs Ltd. | 2.95% |
Indus Towers Ltd. | 2.69% |
Ultratech Cement Ltd. | 2.67% |
Polycab India Ltd. | 2.46% |
Reliance Industries Ltd. | 2.44% |
Kaynes Technology India Ltd. | 2.43% |
Axis Bank Ltd. | 2.08% |
Name | Fatema Pacha | - |
Start Date | 21 Dec 2020 | - |
Name
Start Date
Description | The scheme seeks to provide medium to long term capital appreciation through appropriate diversification and taking low risk on business quality. | - |
Launch Date | 20 Apr 2017 | - |
Description
Launch Date